Plain-English translation of NCT07491081 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The EARLY Study is testing whether a blood test using tiny particles called extracellular vesicles can reliably detect ovarian cancer in its early stages. Researchers are collecting blood samples from 1,500 postmenopausal women to understand how to properly collect, store, and transport these samples so the test works accurately. This research could eventually help doctors catch ovarian cancer earlier, when treatment is most effective.
Ovarian cancer is often diagnosed late because there's no reliable early-detection blood test available today. This study is laying the groundwork to develop and validate a new blood test that could screen for ovarian cancer before symptoms appear, similar to how blood tests work for other cancers.
You likely qualify if…
You likely don't qualify if…
Your participation is straightforward and quick. You'll visit a collection site in Queensland, where staff will draw about 30 milliliters (2 tablespoons) of blood using a standard needle. You'll also answer questions about your age, family history, lifestyle, and medical background. Your participation ends after the blood draw — there are no follow-up visits or long-term commitments.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Australia